tradingkey.logo
tradingkey.logo
Suchen

Neuropace Inc

NPCE
Zur Watchlist hinzufügen
16.140USD
+0.370+2.35%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
541.90MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Neuropace Inc Unternehmen

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Neuropace Inc Informationen

BörsenkürzelNPCE
Name des UnternehmensNeuropace Inc
IPO-datumApr 22, 2021
CEOBecker (Joel D)
Anzahl der mitarbeiter184
WertpapierartOrdinary Share
GeschäftsjahresendeApr 22
Addresse455 N. Bernardo Avenue
StadtMOUNTAIN VIEW
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94043
Telefon16502372700
Websitehttps://www.neuropace.com/
BörsenkürzelNPCE
IPO-datumApr 22, 2021
CEOBecker (Joel D)

Führungskräfte von Neuropace Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Neuropace Inc?

Die fünf größten Anteilseigner von Neuropace Inc sind: Mr. Frank M. Fischer

Wie viele Institutionen halten Anteile an Neuropace Inc (NPCE)?

Mit Stand vom 2026Q1 halten 223 Institutionen Anteile an Neuropace Inc, mit einem Gesamtmarktwert von etwa 33.54M, was 99.26% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -4152379.00 gestiegen.